➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson

Last Updated: February 25, 2021

DrugPatentWatch Database Preview

VERSACLOZ Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Versacloz, and what generic alternatives are available?

Versacloz is a drug marketed by Tasman Pharma and is included in one NDA. There is one patent protecting this drug.

This drug has six patent family members in six countries.

The generic ingredient in VERSACLOZ is clozapine. There are thirteen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the clozapine profile page.

US ANDA Litigation and Generic Entry Outlook for Versacloz

A generic version of VERSACLOZ was approved as clozapine by IVAX SUB TEVA PHARMS on November 26th, 1997.

  Start Trial

Summary for VERSACLOZ
International Patents:6
US Patents:1
Suppliers / Packagers: 1
Bulk Api Vendors: 108
Formulation / Manufacturing:see details
DailyMed Link:VERSACLOZ at DailyMed
Drug patent expirations by year for VERSACLOZ
Pharmacology for VERSACLOZ

US Patents and Regulatory Information for VERSACLOZ

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Tasman Pharma VERSACLOZ clozapine SUSPENSION;ORAL 203479-001 Feb 6, 2013 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.